BeStock  
Stocks › Biotechnology › STOK

Stoke Therapeutics STOK

US equityMarket cap rank #2770Biotechnology
$26.81 −$0.12 (-0.45%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $27.40 +2.20%
Open$26.39
Prev close$26.93
Day range$25.94 – $27.78
Volume615.8K
Market cap$1.75B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±8.5%last 5 reports
Closed higher3 of 560% of the time
Best reaction+25.0%
Worst reaction-9.9%

Stock move on the day after each report

+25.0%2025/Q2-9.9%2025/Q3+0.3%2026/Q1+7.1%2026/Q2-0.2%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q329 Oct 2026After Market±16.8%-0.23%Within range
2026/Q23 Aug 2026After Market±10.1%+7.14%Within range
2026/Q17 May 2026After Market±17.5%+0.31%Within range
2025/Q34 Nov 2025After Market±20.9%-9.94%Within range
2025/Q212 Aug 2025After Market±20.9%+24.98%Bigger than priced

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026

Revenue$11.26M+5.9% YoY
Operating profit-$77.32M-79.4% YoY
Net profit-$73.64M-92.0% YoY
Diluted EPS-$1.08-66.2% YoY
Free cash flow-$65.54M-114.9% YoY
Operating cash flow-$62.69M

Revenue, last 8 quarters

$22.6MDec '24$158.6MMar '25$13.8MJun '25$10.6MSep '25$1.4MDec '25$6.2MMar '26$9.3MJun '26$11.3MSep '26

Net profit, last 8 quarters

$-10.5MDec '24$112.9MMar '25$-23.5MJun '25$-38.3MSep '25$-57.9MDec '25$-50.0MMar '26$-61.6MJun '26$-73.6MSep '26

Profitability & balance sheet

Operating margin-913.2%
Net margin-862.1%
Return on equity-73.6%
Return on assets-63.4%
Return on invested capital-73.2%
Current ratio7.24
Liabilities / assets13.3%
Cash & investments$319.19M
Net cash (debt)$319.19M

Discussion

No comments yet — be the first to weigh in on STOK.

Sign in to join the discussion.

Scroll to Top